A Practical Framework for Recognizing Time-Sensitive Indications, Optimizing Standard Care, and Requesting Hyperbaric Consultation
Hyperbaric oxygen therapy, commonly abbreviated as HBOT, is a specialized medical treatment rather than a general method for accelerating recovery. It is most appropriate when increased oxygen delivery, pressure-mediated bubble reduction, edema control, antimicrobial support, or vascular remodeling can address a defined pathophysiologic problem.
Physicians should consider referral when a patient has a recognized hyperbaric indication, the tissue or organ remains potentially salvageable, and HBOT can be integrated without delaying definitive treatment. The referral should identify a specific objective, such as preserving a threatened flap, reducing neurologic injury after carbon monoxide poisoning, treating delayed radiation damage, or supporting an advanced hypoxic wound.
The Undersea and Hyperbaric Medical Society, or UHMS, maintains an indication framework that includes acute emergencies, tissue-salvage conditions, severe infections, selected chronic wounds, delayed radiation injury, and other defined disorders. Clinical recognition by UHMS is separate from Medicare or commercial insurance coverage, which may apply narrower eligibility and documentation requirements. (UHMS)
A Referral Should Address a Specific Clinical Problem
A useful hyperbaric referral should answer several questions:
- What is the precise diagnosis?
- Why is oxygen delivery or pressure therapy relevant?
- Is the condition emergent, urgent, or elective?
- What standard treatments have already been completed?
- What tissue, function, organ, or clinical outcome is being preserved?
- Is the patient stable enough for transport and chamber treatment?
A referral based only on a description such as “nonhealing wound” or “poor circulation” is rarely sufficient. The hyperbaric physician must determine whether the wound is failing because of hypoxia, ischemia, infection, radiation injury, inadequate source control, repeated pressure, or another problem.
HBOT should not replace surgery, revascularization, antimicrobial therapy, offloading, debridement, transfusion, or critical care. It is generally used to support those treatments when a recognized oxygen-responsive problem remains.
Refer Immediately for Air or Gas Embolism
Air or gas entering the arterial circulation can obstruct blood flow to the brain, spinal cord, heart, or other organs. It may occur during surgery, central venous catheter manipulation, interventional procedures, pulmonary barotrauma, diving, or mechanical ventilation.
Possible findings include:
- Sudden loss of consciousness
- Seizure
- Confusion
- Focal weakness
- Visual disturbance
- Chest pain
- Cardiovascular instability
- Stroke-like symptoms after a procedure
The patient should receive high-concentration oxygen and emergency stabilization while hyperbaric consultation is initiated. Recompression reduces gas-bubble volume, while oxygen accelerates inert-gas elimination and supports ischemic tissue.
A suspected arterial gas embolism should be treated as a time-sensitive emergency. Imaging should not delay consultation when the clinical history is convincing, because intravascular gas may no longer be visible by the time CT or MRI is completed. Air or gas embolism is recognized by UHMS and covered under the current Medicare national policy. (UHMS)
Refer Immediately for Decompression Illness
Decompression illness includes decompression sickness and arterial gas embolism associated with diving or another significant pressure exposure.
Symptoms may include:
- Deep joint or limb pain
- Numbness or tingling
- Weakness
- Difficulty walking
- Vertigo or hearing loss
- Bladder dysfunction
- Confusion
- Shortness of breath
- Cardiovascular collapse
The highest practical concentration of oxygen should be administered immediately. The patient should remain at rest, and unnecessary altitude exposure should be avoided during transport when possible.
A normal dive computer, symptom improvement with surface oxygen, or a delay in presentation does not exclude decompression sickness. Physicians should contact a diving-medicine or hyperbaric specialist rather than waiting for confirmatory imaging or laboratory testing. Recompression remains the definitive treatment for clinically significant decompression illness. (Centers for Medicare & Medicaid Services)
Refer Early for Significant Carbon Monoxide Poisoning
Every patient with suspected carbon monoxide poisoning should receive 100 percent oxygen promptly. Hyperbaric consultation is particularly appropriate when the patient has:
- Loss of consciousness
- Persistent confusion or neurologic impairment
- Seizure
- Cardiac ischemia or biomarker elevation
- Severe metabolic acidosis
- Significant exposure symptoms during pregnancy
- A high carboxyhemoglobin concentration
- A severe clinical presentation despite a lower measured concentration
The decision should not be made from the carboxyhemoglobin level alone. The measured value may fall substantially after the patient leaves the exposure and receives oxygen, while neurologic and cardiac injury may continue.
Patients exposed during a fire should also be evaluated for airway injury, pulmonary damage, trauma, and cyanide toxicity. HBOT must not delay airway management, antidotal therapy, cardiovascular stabilization, or burn care.
Carbon monoxide poisoning is a recognized hyperbaric indication and is covered by Medicare. The strongest referral pathway begins oxygen immediately and involves the hyperbaric center while the emergency evaluation is still underway. (Centers for Medicare & Medicaid Services)
Treat Sudden Monocular Vision Loss as an Emergency
Central retinal artery occlusion may produce sudden, painless loss of vision in one eye. The retinal tissue has limited tolerance for ischemia, making early recognition and consultation important.
A patient with suspected retinal artery occlusion needs urgent ophthalmologic and stroke evaluation. HBOT may provide oxygen to the inner retina through diffusion from the choroidal circulation while the arterial obstruction and systemic vascular risk are evaluated.
Referral should not be postponed until a routine outpatient ophthalmology appointment. The hyperbaric center should be contacted as soon as the diagnosis is suspected because the potential for visual recovery generally declines as retinal ischemia continues. UHMS includes central retinal artery occlusion within its arterial-insufficiency indications. (UHMS)
HBOT does not replace evaluation for embolic disease, giant cell arteritis, carotid disease, cardiac sources, or cerebral ischemia. The patient still requires an appropriate stroke and vascular workup.
Refer Urgently for Acute Traumatic Ischemia and Crush Injury
Severe trauma can create a cycle of edema, microvascular compression, tissue hypoxia, inflammation, and progressive necrosis. HBOT may support viable tissue in selected crush injuries, compartment syndromes, replantations, and other acute traumatic ischemias.
Referral may be appropriate when:
- A limb remains threatened after vascular repair
- Severe edema compromises marginal tissue
- A crush injury places muscle and skin at risk
- A replanted or revascularized body part remains ischemic
- Tissue remains compromised after fasciotomy
- A high-energy open fracture has extensive soft-tissue injury
HBOT must not delay hemorrhage control, revascularization, fracture stabilization, fasciotomy, debridement, or another required operation. A closed compartment that needs surgical decompression cannot be treated adequately with oxygen alone.
Medicare recognizes acute traumatic peripheral ischemia and crush injuries involving the suturing of severed limbs when function, limb, or life is threatened. (Centers for Medicare & Medicaid Services)
Refer Early for Compromised Grafts and Flaps
A healthy graft or flap does not require routine HBOT. Referral becomes appropriate when a reconstruction shows evidence of hypoxia, ischemia, or venous compromise and viable tissue may still be salvaged.
Warning findings include:
- Increasing pallor or cyanosis
- Cool tissue
- Delayed capillary refill
- Progressive edema
- Loss of a Doppler signal
- Epidermal separation
- Expanding necrosis
- Failure of a skin graft to establish uptake
The operating surgeon should evaluate the patient immediately. A hematoma, thrombosed anastomosis, twisted pedicle, constricting dressing, fluid collection, or mechanical disruption requires direct correction.
HBOT may then support tissue that remains compromised after remediable causes have been addressed. Referral should occur while the tissue remains potentially viable, not after the entire reconstruction has become irreversibly necrotic. Medicare covers preparation and preservation of compromised skin grafts, but not HBOT as the primary management of ordinary wounds. (Centers for Medicare & Medicaid Services)
Refer Urgently for Necrotizing and Clostridial Infections
Necrotizing soft tissue infections and clostridial myonecrosis require emergency surgery, broad antimicrobial therapy, resuscitation, and critical care.
Findings that should prompt immediate surgical evaluation include:
- Pain disproportionate to visible skin changes
- Rapidly progressive swelling or erythema
- Bullae or ecchymosis
- Crepitus
- Skin anesthesia
- Severe systemic toxicity
- Shock
- Gas within deep tissue
HBOT may be considered after urgent source control has begun. Potential benefits include increased oxygenation of threatened tissue, support for leukocyte microbial killing, reduction of edema, and inhibition of selected anaerobic organisms or toxin production.
A chamber treatment must never take priority over an indicated debridement. Transfer solely for HBOT may be inappropriate when it removes an unstable patient from immediate surgical care.
Gas gangrene and progressive necrotizing infections are included in the Medicare coverage framework, while UHMS also recognizes necrotizing soft tissue infection as a hyperbaric indication. (Centers for Medicare & Medicaid Services)
Consider Referral for Exceptional Severe Anemia
HBOT may function as a temporary bridge in exceptional life-threatening anemia when red blood cell transfusion cannot be performed because compatible blood is unavailable, transfusion is declined, or another extraordinary barrier exists.
The clinical concern is inadequate tissue oxygen delivery, which may present with:
- Myocardial ischemia
- Altered mental status
- Persistent lactic acidosis
- Hemodynamic instability
- Progressive organ dysfunction
HBOT increases dissolved plasma oxygen temporarily. It does not restore red blood cell mass, stop hemorrhage, or replace definitive hematologic treatment.
Referral should occur alongside hemorrhage control, iron replacement, erythropoietic support when appropriate, blood-conservation measures, and critical care. The receiving center must be capable of managing the patient’s full acuity under pressure.
Severe anemia is recognized within the UHMS indication framework, but Medicare’s national policy does not currently cover exceptional blood-loss anemia. (UHMS)
Refer Selected Patients With Delayed Radiation Injury
Radiation can produce progressive vascular injury, fibrosis, chronic tissue hypoxia, ulceration, bleeding, and impaired healing months or years after cancer treatment.
Referral may be appropriate for suspected:
- Radiation cystitis
- Radiation proctitis
- Soft tissue radionecrosis
- Osteoradionecrosis
- Nonhealing wounds within a radiation field
- Reconstructive failure involving irradiated tissue
The referring physician should provide radiation records when available, including the treatment site, dose, dates, and relevant operative history.
Other causes must still be evaluated. Hematuria requires appropriate urologic assessment, rectal bleeding requires gastrointestinal or colorectal evaluation, and a new wound in a previous cancer field may require biopsy or imaging to exclude recurrent malignancy.
Medicare covers soft tissue radionecrosis and osteoradionecrosis when HBOT is provided as an adjunct to conventional treatment. (Centers for Medicare & Medicaid Services)
Referral is most useful when the diagnosis has been characterized and the treatment objective is clear. HBOT may be used to reduce bleeding, improve tissue health, support healing, or prepare selected patients for debridement and reconstruction.
Refer Chronic Osteomyelitis After Standard Treatment Has Failed
HBOT may be considered for chronic refractory osteomyelitis, not for every case of bone infection.
A useful referral should document:
- The affected bone and duration of infection
- Imaging findings
- Operative and pathology reports
- Deep tissue or bone cultures
- Antimicrobial regimens
- Debridement history
- Hardware status
- Vascular assessment
- Evidence of persistence or recurrence
Necrotic bone, abscesses, unstable hardware, and biofilm require appropriate surgical and infectious disease management. HBOT may support oxygen-dependent immune function, bone repair, and antimicrobial effectiveness in selected hypoxic tissue, but it does not provide source control.
Medicare covers chronic refractory osteomyelitis that has not responded to conventional medical and surgical management. (Centers for Medicare & Medicaid Services)
Referral before adequate treatment has been attempted may be premature. Waiting until infection has produced extensive destruction may also reduce the likelihood of successful reconstruction. Early discussion with the hyperbaric team can help determine whether the patient is approaching a refractory course.
Refer Selected Advanced Diabetic Foot Ulcers
A diabetic foot ulcer should not be referred for HBOT solely because it has been present for several weeks.
The wound first requires comprehensive evaluation and management, including:
- Vascular assessment and revascularization when feasible
- Pressure offloading
- Debridement
- Infection treatment
- Glucose management
- Nutritional assessment
- Moisture-balanced wound care
- Appropriate surgical consultation
The 2023 International Working Group on the Diabetic Foot guideline conditionally recommends considering systemic HBOT for neuro-ischemic or ischemic diabetes-related foot ulcers when standard care alone has failed and the resources needed to provide treatment are available. The guideline rates the certainty of evidence as low and emphasizes appropriate patient selection.
For Medicare coverage, the patient must generally have type 1 or type 2 diabetes, a lower-extremity wound related to diabetes, a Wagner grade III or higher wound, and no measurable healing after at least 30 days of standard wound therapy. HBOT must continue alongside comprehensive wound care, and measurable progress must be reassessed during treatment. (Centers for Medicare & Medicaid Services)
Referral documentation should include wound measurements, depth, Wagner classification, vascular findings, offloading method, debridement history, infection management, imaging, glucose control, and the response to standard care.
A superficial ulcer that remains open because the patient continues walking on it without effective offloading is not primarily an oxygen-delivery problem.
Refer Promptly for Sudden Sensorineural Hearing Loss
Sudden sensorineural hearing loss is an urgent otologic condition, often presenting as rapid unilateral hearing loss with tinnitus, ear fullness, or vertigo.
The American Academy of Otolaryngology–Head and Neck Surgery guideline states that clinicians may offer or refer for HBOT combined with steroid therapy within two weeks of symptom onset. HBOT combined with steroids may also be offered as salvage treatment within one month when hearing recovery is incomplete. (AAO-HNS)
The patient should first receive prompt evaluation to distinguish sensorineural loss from conductive hearing loss and identify alternative causes. Audiometry and otolaryngology involvement are important, but delays in routine scheduling can reduce the available treatment window.
HBOT should be presented as an option within a shared decision-making process rather than a guaranteed method of restoring hearing. The evidence remains imperfect, and treatment requires repeated chamber sessions in addition to steroid management.
Consider Referral for Selected Intracranial Abscesses
HBOT may be considered in selected intracranial abscesses, particularly when infection is multiple, deep, recurrent, associated with immune compromise, or inadequately responsive to surgery and antimicrobial therapy.
This is not a routine first-line treatment. Neurosurgical drainage, organism identification, antimicrobial therapy, imaging, and management of intracranial pressure remain essential.
Referral should involve direct communication among neurosurgery, infectious disease, critical care, and hyperbaric medicine. The chamber facility must be capable of managing neurologic deterioration, seizures, mechanical ventilation, and invasive monitoring when those needs are present.
Intracranial abscess is recognized within the UHMS hyperbaric indication framework but is not included among the nationally covered Medicare conditions in NCD 20.29. (UHMS)
Do Not Delay Definitive Care While Seeking HBOT
For emergency conditions, HBOT consultation should occur in parallel with stabilization and definitive treatment.
Examples include:
- Surgery before or between treatments for necrotizing infection
- Fasciotomy for confirmed compartment syndrome
- Vascular repair for traumatic arterial disruption
- Revision of a thrombosed flap pedicle
- Airway stabilization in smoke inhalation
- Antimicrobial therapy and drainage for infection
- Hemorrhage control in severe anemia
UHMS guidance on emergent and urgent services emphasizes prompt treatment at the closest appropriate facility for stable patients while directing unstable or critically ill patients to a center capable of providing the required level of care. (UHMS)
The chamber should support the treatment plan. It should never become an obstacle between the patient and a more urgent operation or resuscitative intervention.
Information the Hyperbaric Center Needs
A high-quality referral should include the information required to determine indication, urgency, safety, and treatment feasibility.
Useful records may include:
- Diagnosis and symptom timeline
- Treatment objective
- Current clinical stability
- Operative reports
- Imaging
- Culture and pathology results
- Radiation records
- Wound measurements and photographs
- Vascular studies
- Audiograms
- Carboxyhemoglobin, blood gas, lactate, ECG, and cardiac biomarkers
- Dive profile and neurologic findings
- Current medications
- Implanted and external medical devices
- Pulmonary history
- Prior chamber exposure
For an urgent case, physicians should call the hyperbaric service directly rather than relying solely on an electronic referral that may not be reviewed immediately.
The referring team should describe why the condition is urgent, which interventions have been completed, and what level of monitoring the patient currently requires.
Safety Screening Should Begin Before Transfer
The hyperbaric physician performs the definitive treatment assessment, but the referring clinician can identify issues that may affect chamber safety.
Relevant considerations include:
- Known or suspected pneumothorax
- Pulmonary air trapping or significant bullous disease
- Recent thoracic procedures
- Uncontrolled seizure activity
- Fever
- Glucose instability
- Difficulty equalizing ear pressure
- Severe claustrophobia
- Hemodynamic instability
- Implanted medical devices
- Mechanical ventilation
- Continuous infusions
- Pregnancy
- Medications that may affect oxygen tolerance
Significant pulmonary air trapping and a history of spontaneous pneumothorax require careful risk-benefit analysis. A pneumothorax may require tube thoracostomy before recompression, particularly when pressure changes could cause expansion during decompression. (UHMS)
A potential safety concern does not always eliminate treatment, especially during a life-threatening emergency. It determines the preparation, chamber type, equipment, monitoring, and clinical team required.
Choose a Qualified Medical Hyperbaric Facility
Patients should be referred to a facility that can safely manage the diagnosis and level of acuity.
A stable outpatient wound program may not be equipped to accept an intubated patient with arterial gas embolism or necrotizing infection. A critical-care hyperbaric center may require direct physician-to-physician communication before transfer.
The FDA states that HBOT chambers are Class II medical devices and advises facilities to follow manufacturer instructions, maintain staff training, monitor patients throughout treatment, complete recommended maintenance, and enforce strict fire-prevention controls. FDA-cleared devices can be identified under product code CBF. (U.S. Food and Drug Administration)
Important facility questions include:
- Is the center medically supervised?
- Does it treat the specific indication?
- Can it accept emergency or inpatient cases?
- Can it manage mechanical ventilation and infusions?
- Is a surgeon, intensivist, or other specialist available when needed?
- Does it have established emergency and fire-safety systems?
- Is it accredited or actively aligned with recognized hyperbaric standards?
A low-pressure wellness chamber should not be assumed to provide the oxygen dose, equipment, supervision, or emergency capability required for clinical HBOT.
Know When HBOT Referral Is Unlikely to Help
Referral is generally not appropriate merely because a condition involves inflammation, fatigue, a chronic wound, or slow recovery.
Examples that usually require another primary approach include:
- A normally healing surgical incision
- An uncomplicated skin graft or flap
- A superficial diabetic ulcer without optimized offloading
- Cellulitis without a recognized hyperbaric indication
- Untreated arterial obstruction
- An undrained abscess
- Routine chronic anemia
- General wellness or athletic recovery
- Cosmetic scar improvement
- Uncomplicated postoperative recovery
- Neurologic conditions offered outside established care or a structured research protocol
The absence of an established indication does not mean that oxygen has no biologic effect. It means that sufficient clinical evidence, treatment standardization, or patient-selection guidance may not exist to support routine referral.
Physicians can still contact a qualified hyperbaric specialist when the diagnosis is uncertain. Consultation does not obligate the patient to undergo treatment.
Clinical Appropriateness and Insurance Coverage Must Be Evaluated Separately
UHMS indication recognition, FDA device clearance, Medicare coverage, and commercial payer authorization are different determinations.
A condition may be recognized clinically but not nationally covered by Medicare. Acute thermal burns and exceptional blood-loss anemia are examples of conditions that may be recognized within hyperbaric medicine but remain nationally noncovered under the current Medicare policy. Conversely, Medicare coverage for a listed diagnosis still requires documentation that the patient satisfies the applicable clinical criteria. (Centers for Medicare & Medicaid Services)
The hyperbaric center should verify coverage, authorization, and documentation requirements. The referring physician can support this process by providing complete records rather than relying on a diagnosis code alone.
For emergency conditions, financial authorization should not delay stabilization or time-sensitive specialist consultation.
The Best Time to Refer Is Before Salvage Becomes Impossible
HBOT is often most valuable in tissue that is threatened but still viable. Referral after a flap is completely necrotic, a retina has sustained prolonged irreversible ischemia, or a wound has progressed without appropriate vascular and surgical care may come too late to change the outcome.
Early referral does not always mean immediate treatment. It allows the hyperbaric physician to determine whether HBOT is indicated, what prerequisites remain, and when treatment would have the greatest biologic relevance.
Physicians should refer when there is a recognized diagnosis, a defined therapeutic objective, and a reasonable expectation that increased oxygen delivery or recompression can influence the patient’s outcome. For emergencies, consultation should occur immediately. For chronic conditions, referral should follow careful diagnostic workup and optimization of standard care.
The most effective referrals connect HBOT to a coordinated treatment plan rather than treating the chamber as an isolated solution.
